Hyperplastic nodular hepatic lesions following end-to-side portacaval shunting in childhood

Internal Medicine

Volumn 46, Issue 15, 2007, Pages 1203-1208

  Fukushima, Nobuyoshi ^a   Kuromatsu, Ryoko ^a   Uchiyama, Daiji ^a   Itano, Satoshi ^a,b   Takata, Akio ^a   Ando, Eiji ^a   Sumie, Shuji ^a   Torimura, Takuji ^a   Uchida, Masafumi ^a   Nakashima, Osamu ^a   Kojiro, Masamichi ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kurume Chuo Hospital   (Japan)

Author keywords

Focal nodular hyperplasia; Hyperestrogenemia; Portacaval anastomosis

Indexed keywords

AMMONIA; ASPARTATE AMINOTRANSFERASE; CD34 ANTIGEN; CONTRAST MEDIUM; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY; HYALURONIC ACID; INDOCYANINE GREEN; LACTATE DEHYDROGENASE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ALBUMIN BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; END TO SIDE ANASTOMOSIS; ESTRADIOL BLOOD LEVEL; FATTY LIVER; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFERIOR CAVA VEIN; JAPANESE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER HYPERPLASIA; LIVER SINUSOID; MALARIA; MALE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT CARE; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTOCAVAL SHUNT; PROTEIN BLOOD LEVEL; SPLENIC VEIN; SUPERIOR MESENTERIC VEIN; THREE DIMENSIONAL IMAGING; UPPER GASTROINTESTINAL BLEEDING; BLOOD; HYPERPLASIA; LIVER; LIVER DISEASE; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

ESTRADIOL; HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PORTACAVAL SHUNT, SURGICAL;

EID: 34548068022     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6419     Document Type: Article

References (30)

1. Hallett EB, Holton GW, Paterson JC, Schilling JA. Liver blood and following Eck fistula; liver blood flow before and after splenectomy. Surg Gynecol Obstet 95: 401-406, 1952.
2. Blakemore AH, Lord JW. A non-suture method of blood vessel anastmosis: review of experimental study. Reports of clinical cases. Ann Surg 121: 435-453, 1945.
3. Morgan G, Superina, R. Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. J Pediatr Surg 29: 1239-1241, 1994.
4. Howard ER, Davenport M. Congenital extrahepatic portocaval shunts-the Abernethy malformation. J Pediatr Surg 32: 494-497, 1997.
5. Hirohashi K, Yamamoto T, Tanaka S, et al. Immmunohistochemical demonstration of sinusoidal capillarization in human benign liver tumors: distinction from neoangiogenesis. Hepatol Res 28: 87-93, 2004.
6. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathormorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24; 807-812, 1996.
7. De Gaetano AM, Gui B, Macis G, Manfredi R, Di Stasi C. Congenital absence of the portal vein associated with focal nodular hyperplasia in the liver in an adult woman: imaging and review of the literature. Abdom Imaging 29: 455-459, 2004.
8. Schmidt S, Saint-Paul MC, Anty R, Bruneton JN, Gugenheim J, Chevallier P. Multiple focal nodular hyperplasia of the liver associated with congenital absence of the portal vein. Gastroenterol Clin Biol 30: 310-313, 2006 (in French, Abstract in English).
9. Takagaki K, Kodaira M, Kuriyama S, et al. Congenital absence of the portal vein complicating hepatic tumors. Intern Med 43: 194-198, 2004.
10. Pichon N, Maisonnette F, Pichon-Lefievre F, Valleix D, Pillegand B. Hepatocarcinoma with congenital agenesis of the portal vein. Jpn J Clin Oncol 33: 314-316, 2003.
11. Tsuji K, Naoki K, Tachiyama Y, et al. A case of congenital absence of the portal vein. Hepatol Res 31: 43-47, 2005.
12. Grazioli L, Alberti D, Olivetti L, et al. Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur Radiol 10: 820-825, 2000.
13. Kanamori Y, Hashizume K, Kitano Y, Sugiyama M, Motoi T, Tange T. Congenital extrahepatic portocaval shunt (Abernethy type 2), huge liver mass, and patent ductus arteriosus-a case report of its rare clinical presentation in a young girl. J Pediatr Surg 38: E15, 2003.
14. Tanaka Y, Takayanagi M, Shiratori Y, et al. Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver. J Gastroenterol 38: 288-294, 2003.
15. Turkbey B, Karcaaltincaba M, Demir H, Akcoren Z, Yuce A, Haliloglu M. Multiple hyperplastic nodules in the liver with congenital absence of portal vein: MRI findings. Pediatr Radiol 36: 445-448, 2006.
16. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5: 1194-1200, 1985.
17. Kondo F. Benign nodular hepatocelular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 16: 1319-1328, 2001.
18. Starzl TE, Francavilla A, Halgrimson CG, et al. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 137: 179-199, 1973.
19. Francavilla A, Starzl TE, Porter K, et al. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology 14: 665-670, 1991.
20. Grün R, Grün M, Rolfs A, Kaffarnik H. Hyperestrogenemia following various shunt operations: on the role of estrogens in the development of focal nodular hyperplasia of the liver. Z Gastroenterol 27: 378-382, 1999 (in German, Abstract in English).
21. Pain JA, Gimson AE, Williams R, Howard ER. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 32: 524-527, 1991.
22. Eisenfeld AJ, Aten R, Weinberger M, Haselbacher G, Halpern K, Krakoff L. Estrogen receptor in the mammalian liver. Science 191: 862-865, 1976.
23. Rasenack U. Changes in the liver and brain after portacaval and modified portacaval end-to-side anastomosis: histology, autoradiography and clinical studies. Fortschr Med 99: 107-112, 1981 (in German, Abstract in English).
24. Takamura M, Mugishima H, Oowada M, Harada K, Uchida T. Type Ia glycogen storage disease with focal nodular hyperplasia in siblings. Acta Paediatr Jpn 37: 510-513, 1995.
25. Sakatoku H, Hirokawa Y, Inoue M, Kojima M, Yabana T, Sakurai M. Focal nodular hyperplasia in an adolescent with glycogen storage disease type I with mesocaval shunt operation in childhood: a case report and review of the literature. Acta Paediatr Jpn 38: 172-175, 1996.
26. Bjorneboe M, Andersen JR, Christensen U, Skinhoj P, Jensen OM. Does a portal-systemic shunt increase the risk of primary hepatic carcinoma in cirrhosis of the liver? Scand J Gastroenterol 20: 59-64, 1985.
27. Banares R, Nunez O, Escudero M, et al. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma. Hepatology 41: 566-571, 2005.
28. Webster MW, Van Thiel DH, Bron KM, Barnes EL. Hepatic adenoma associated with portasystemic shunting in a young woman. Digestion 19: 328-334, 1979.
29. Desai S, Prabhu SR, Shrividya S. Fibrosing necrotic nodule of the liver. Indian J Gastroenterol 14: 23-24, 1995.
30. Lu SN, Lin TM, Chen CJ, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 62: 2051-2055, 1988.